Mercom Capital Group September 9, 2021
The financial terms of the acquisition were not disclosed
Recuro Health, a digital virtual care platform, acquired MyLifeIQ, an epigenetics and precision medicine platform. The terms of the acquisition were not disclosed.
MyLifeIQ precision medicine platform captures data and delivers the uniqueness of each person, pulling together the variables involved in health, including DNA, wearable data, and lifestyle assessments.
Recently, Recuro Health, announced the acquisition of SupDoc, an AI-enabled virtual health solution for care delivery. The financial terms of the acquisition were not disclosed.
Recuro offers a cloud-based virtual care platform with a curated suite of digital solutions – from primary care and behavioral health to at-home testing and genetic screening. According to the company, these digital solutions allow patients...
Today's Sponsors
Today's Sponsor